Tennessee
Prescription drug spending and prescribing in Tennessee, from Medicare Part D and Medicaid, with the life-science companies raising money there and state attorney general health-care antitrust cases. Compare every state.
In 2024, Medicare Part D plans paid $7.1B for prescriptions written in Tennessee, the 13th most of 52 states and territories, and 4.4% of its claims were opioids against 3.5% nationally.
- Medicare Part D, 2024: $7.1B
- Medicaid drugs, 2025: $1.6B
- Opioid share of claims: 4.4%
- Life-science raises, 2 years: $363M
How It Prescribes
Medicare Part D, 2024, by the prescriber's state| Share of Part D claims | Tennessee | United States | Difference |
|---|---|---|---|
| Opioids | 4.4% | 3.5% | +24% |
| Antibiotics | 4.6% | 4.4% | +4% |
| Antipsychotics | 1.6% | 1.7% | -8% |
Most Distinctive Drugs
Prescribed most out of line with the rest of the country: the drug's share of Tennessee's claims against its share nationally| Drug | Against national rate | Claims |
|---|---|---|
| Promethazine Hcl | 2.9× | 98,474 |
| Rsv Vacc, Pref A And Pref B/Pf | 2.1× | 87,269 |
| Buprenorphine Hcl/Naloxone Hcl | 2.0× | 96,726 |
| Oxycodone Myristate | 2.0× | 19,432 |
| Prasugrel Hcl | 1.9× | 16,410 |
| Cefdinir | 1.8× | 110,770 |
| Oxycodone Hcl/Acetaminophen | 1.8× | 422,158 |
| Indapamide | 1.8× | 17,293 |
| Medroxyprogesterone Acetate | 1.7× | 17,323 |
| Benazepril/Hydrochlorothiazide | 1.7× | 11,232 |
Biggest Medicaid Drugs
What Tennessee's Medicaid program paid pharmacies, before rebates; see every drugLife-Science Fundraising
49 Form D raises by companies based in Tennessee in the last two years; the 10 largest. See all raises- Thyme Care, Inc.$97M · Other health care · Sep 25, 2025
- ObjectiveHealth, Inc.$47M · Other health care · Oct 8, 2025
- Imagine Pediatrics Holdings LLC$38M · Other health care · Mar 13, 2025
- Wellvana Health, LLC$20M · Other health care · Nov 18, 2024
- EvidenceCare, Inc.$15M · Other health care · Mar 24, 2025
- LYNCH REGENERATIVE MEDICINE, LLC$15M · Other health care · Jul 15, 2026
- Optura, Inc.$13M · Other health care · Apr 1, 2026
- Upperline Health Holdings, Inc.$12M · Other health care · Feb 28, 2025
- One to One Health, Inc.$12M · Other health care · Feb 4, 2026
- MODEL ONCOLOGY, LLC$11M · Other health care · Oct 19, 2026
State Attorney General Health-Care Cases
Antitrust cases Tennessee joined, newest first; see every case- Connecticut, et al. v. Sandoz, et al., Case No. 20-cv-3539 (E.D. Pa. June 10, 2020), MDL 2724 (E.D. Pa.)2020 · Pending
- Connecticut et al. v. Teva Pharmaceuticals USA, Inc. et al., No. 2:19-cv-02407, (E.D. Pa. filed in MDL 05/30/2019)2019 · Pending
- State of Wisconsin et al. v. Indivior, No. 16-5073 (E.D. Pa. Sept. 22,2016)2016 · Pending
- New York et al. v. Cephalon, No. 2:16-cv-04234 (E.D. Pa. Aug. 4, 2016)2016 · Settled
- Maryland v. SmithKline Beecham Corp., No. 2:06-cv-01298-JP (E.D.Pa Mar. 27, 2006)2006 · Settled
- State of Colorado et al v. Warner Chilcott, 1:05-cv-02182 (D.D.C.2005)2005 · Settled
- Maryland et al. v. Perrigo Company, No. 1:04CV01398 (D.D.C. Aug. 17, 2004)2004 · Settled
- Texas et al. v. Organon (Remeron), No. 04-5126 (D.N.J. 2004)2004 · Settled
- In re Cardizem CD Antitrust Litigation 99-MD-1278 (E.D. Mich. Jan. 29, 2003), 332 F.3d 896 (6th Cir. 2003)2003 · Settled
- Ohio, et al, v. Bristol-Myers Squibb Co., et al.(D.D.C. 2002); see also In re Buspirone Antitrust Litigation,Case No. 01 CV 11401, MDL…2002 · Settled
Other States
Alabama · Alaska · Arizona · Arkansas · California · Colorado · Connecticut · Delaware · District of Columbia · Florida · Georgia · Hawaii · Idaho · Illinois · Indiana · Iowa · Kansas · Kentucky · Louisiana · Maine · Maryland · Massachusetts · Michigan · Minnesota · Mississippi · Missouri · Montana · Nebraska · Nevada · New Hampshire · New Jersey · New Mexico · New York · North Carolina · North Dakota · Ohio · Oklahoma · Oregon · Pennsylvania · Puerto Rico · Rhode Island · South Carolina · South Dakota · Texas · Utah · Vermont · Virginia · Washington · West Virginia · Wisconsin · Wyoming
Part D is by the prescriber's state, Medicaid by the paying state program, and Form D by the issuer's stated address. Amounts are before manufacturer rebates. Refreshed weekly. CMS Medicare Part D Prescribers by Geography; CMS State Drug Utilization Data; SEC Form D; NAAG